| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |